The combination of Scholar Rock (SRK-181) and Pembrolizumab is generally well-tolerated.
Scholar Rock控股公司 - SRK-181与Pembrolizumab的联合使用通常耐受良好
The combination of Scholar Rock (SRK-181) and Pembrolizumab is generally well-tolerated.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.